Fresenius Medical Care AG KGaA EBITDA Margin 2010-2025 | FMS
Current and historical EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization) margin for Fresenius Medical Care AG KGaA (FMS) over the last 10 years. The current EBITDA margin for Fresenius Medical Care AG KGaA as of March 31, 2025 is .
| Fresenius Medical Care AG KGaA EBITDA Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM EBITDA | EBITDA Margin |
| 2025-03-31 | $20.94B | $3.33B | 15.92% |
| 2024-12-31 | $20.92B | $3.39B | 16.21% |
| 2024-09-30 | $20.87B | $3.54B | 16.95% |
| 2024-06-30 | $21.01B | $3.45B | 16.43% |
| 2024-03-31 | $21.13B | $3.45B | 16.33% |
| 2023-12-31 | $21.06B | $3.38B | 16.04% |
| 2023-09-30 | $20.82B | $3.41B | 16.40% |
| 2023-06-30 | $20.58B | $3.50B | 17.01% |
| 2023-03-31 | $20.38B | $3.42B | 16.78% |
| 2022-12-31 | $20.44B | $3.53B | 17.27% |
| 2022-09-30 | $20.63B | $3.62B | 17.53% |
| 2022-06-30 | $20.73B | $3.73B | 18.01% |
| 2022-03-31 | $20.87B | $3.93B | 18.84% |
| 2021-12-31 | $20.84B | $4.11B | 19.73% |
| 2021-09-30 | $20.79B | $4.27B | 20.53% |
| 2021-06-30 | $20.71B | $4.47B | 21.59% |
| 2021-03-31 | $20.53B | $4.66B | 22.69% |
| 2020-12-31 | $20.40B | $4.67B | 22.90% |
| 2020-09-30 | $20.21B | $4.66B | 23.06% |
| 2020-06-30 | $19.97B | $4.52B | 22.61% |
| 2020-03-31 | $19.83B | $4.36B | 21.98% |
| 2019-12-31 | $19.57B | $4.33B | 22.10% |
| 2019-09-30 | $19.40B | $4.08B | 21.00% |
| 2019-06-30 | $19.21B | $3.78B | 19.66% |
| 2019-03-31 | $19.35B | $4.64B | 23.98% |
| 2018-12-31 | $19.54B | $4.45B | 22.75% |
| 2018-09-30 | $19.87B | $4.32B | 21.72% |
| 2018-06-30 | $20.25B | $4.46B | 22.02% |
| 2018-03-31 | $20.14B | $3.43B | 17.03% |
| 2017-12-31 | $20.10B | $3.50B | 17.42% |
| 2017-09-30 | $19.55B | $3.69B | 18.88% |
| 2017-06-30 | $19.05B | $3.61B | 18.93% |
| 2017-03-31 | $18.55B | $3.59B | 19.34% |
| 2016-12-31 | $17.91B | $3.41B | 19.06% |
| 2016-09-30 | $17.57B | $3.27B | 18.59% |
| 2016-06-30 | $17.20B | $3.19B | 18.56% |
| 2016-03-31 | $16.98B | $3.09B | 18.17% |
| 2015-12-31 | $16.74B | $3.04B | 18.19% |
| 2015-09-30 | $16.71B | $3.05B | 18.25% |
| 2015-06-30 | $16.59B | $3.02B | 18.23% |
| 2015-03-31 | $16.23B | $3.02B | 18.62% |
| 2014-12-31 | $15.83B | $2.95B | 18.65% |
| 2014-09-30 | $15.38B | $2.93B | 19.06% |
| 2014-06-30 | $14.93B | $2.88B | 19.29% |
| 2014-03-31 | $14.71B | $2.85B | 19.35% |
| 2013-12-31 | $14.61B | $2.88B | 19.71% |
| 2013-09-30 | $14.45B | $2.76B | 19.12% |
| 2013-06-30 | $14.20B | $2.76B | 19.44% |
| 2013-03-31 | $14.02B | $2.78B | 19.83% |
| 2012-12-31 | $13.80B | $2.77B | 20.06% |
| 2012-09-30 | $13.42B | $2.78B | 20.70% |
| 2012-06-30 | $13.24B | $2.73B | 20.64% |
| 2012-03-31 | $13.01B | $2.66B | 20.44% |
| 2011-12-31 | $12.80B | $2.60B | 20.33% |
| 2011-09-30 | $12.64B | $2.56B | 20.22% |
| 2011-06-30 | $12.46B | $2.50B | 20.10% |
| 2011-03-31 | $12.21B | $2.45B | 20.10% |
| 2010-12-31 | $12.05B | $2.43B | 20.14% |
| 2010-09-30 | $11.92B | $2.37B | 19.84% |
| 2010-06-30 | $11.75B | $2.32B | 19.72% |
| 2010-03-31 | $11.57B | $2.26B | 19.53% |
| 2009-12-31 | $11.25B | $2.21B | 19.68% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $0.000B | $20.627B |
| Fresenius Medical Care AG & Co. KGaA is one of the largest integrated providers of products and services for individuals undergoing dialysis. Fresenius Medical provides products and services across the entire dialysis value chain throughout the World. Fresenius Medical manufactures a variety of durable medical devices used in the treatment of End Stage Renal Disease (ESRD). Devices like Hemodialysis Machines, Peritoneal Dialysis Machines, Granuflo Concentrate Mixing Tanks and monitoring devices like the Crit-line platform are included in the company's product pipeline. The company primarily operates in - The Health Care Services segment: Consists of the company's Dialysis Services and the Care-Coordination (non-dialysis laboratory services). The Health Care Products segment: Comprises of the company's Dialysis machines, dialyzers, dialysis solutions, hemodialysis concentrates, bloodline systems, water treatment systems, dialysis drugs and other medical products.. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Intuitive Surgical (ISRG) | United States | $191.463B | 83.86 |
| Thermo Fisher Scientific (TMO) | United States | $155.573B | 18.82 |
| Edwards Lifesciences (EW) | United States | $45.256B | 29.67 |
| Alcon (ALC) | Switzerland | $42.967B | 29.04 |
| IDEXX Laboratories (IDXX) | United States | $42.445B | 48.78 |
| DexCom (DXCM) | United States | $33.345B | 51.54 |
| IQVIA Holdings (IQV) | United States | $27.362B | 15.33 |
| Mettler-Toledo (MTD) | United States | $24.800B | 29.49 |
| STERIS (STE) | Ireland | $23.464B | 25.84 |
| Waters (WAT) | United States | $21.120B | 29.80 |
| SONOVA HOLDING (SONVY) | Switzerland | $17.882B | 0.00 |
| Hologic (HOLX) | United States | $14.509B | 15.77 |
| Sysmex ADR (SSMXY) | Japan | $10.777B | 30.57 |
| Penumbra (PEN) | United States | $9.820B | 77.08 |
| Masimo (MASI) | United States | $9.039B | 33.34 |
| Globus Medical (GMED) | United States | $7.963B | 18.97 |
| Glaukos (GKOS) | United States | $5.775B | 0.00 |
| Teleflex (TFX) | United States | $5.284B | 8.72 |
| TransMedics (TMDX) | United States | $4.399B | 95.63 |
| Integer Holdings (ITGR) | United States | $4.252B | 22.28 |
| PROCEPT BioRobotics (PRCT) | United States | $3.244B | 0.00 |
| LivaNova (LIVN) | United Kingdom | $2.497B | 14.87 |
| Veracyte (VCYT) | United States | $2.100B | 29.46 |
| Nihon Kohden (NHNKY) | Japan | $2.016B | 23.12 |
| Elekta AB (EKTAY) | Sweden | $1.956B | 17.59 |
| Alphatec Holdings (ATEC) | United States | $1.593B | 0.00 |
| Artivion (AORT) | United States | $1.308B | 122.48 |
| Tandem Diabetes Care (TNDM) | United States | $1.273B | 0.00 |
| OPKO Health (OPK) | United States | $1.047B | 0.00 |
| Pulse Biosciences (PLSE) | United States | $1.002B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $0.949B | 5.05 |
| IRadimed (IRMD) | United States | $0.772B | 39.17 |
| SiBone (SIBN) | United States | $0.771B | 0.00 |
| Beta Bionics (BBNX) | United States | $0.650B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.563B | 8.76 |
| RxSight (RXST) | United States | $0.538B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.529B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.526B | 12.32 |
| Delcath Systems (DCTH) | United States | $0.489B | 0.00 |
| AxoGen (AXGN) | United States | $0.477B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.433B | 11.51 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.433B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.401B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.387B | 0.00 |
| NeuroPace (NPCE) | United States | $0.359B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.352B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.336B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.256B | 0.00 |
| 908 Devices (MASS) | United States | $0.242B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.238B | 14.42 |
| Biosig Technologies (BSGM) | United States | $0.232B | 0.00 |
| Neuronetics (STIM) | United States | $0.224B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.220B | 0.00 |
| Inogen (INGN) | United States | $0.193B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.170B | 0.00 |
| CVRx (CVRX) | United States | $0.153B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.153B | 0.00 |
| LENSAR (LNSR) | United States | $0.148B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.144B | 0.00 |
| Accuray (ARAY) | United States | $0.136B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.129B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.113B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.103B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.091B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.079B | 48.20 |
| EnVVeno Medical (NVNO) | United States | $0.073B | 0.00 |
| InspireMD (NSPR) | United States | $0.069B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.064B | 0.00 |
| Hyperfine (HYPR) | United States | $0.057B | 0.00 |
| Spectral AI (MDAI) | United States | $0.054B | 0.00 |
| Positron (POSC) | United States | $0.050B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.046B | 0.00 |
| Precision Optics (POCI) | United States | $0.035B | 0.00 |
| Envoy Medical (COCH) | United States | $0.032B | 0.00 |
| DarioHealth (DRIO) | United States | $0.030B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.029B | 0.00 | |
| Adagio Medical Holdings (ADGM) | United States | $0.019B | 0.00 |
| NexGel (NXGL) | United States | $0.018B | 0.00 |
| PAVmed (PAVM) | United States | $0.011B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.011B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.010B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.008B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.008B | 0.00 |
| Tenon Medical (TNON) | United States | $0.007B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.006B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.004B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.003B | 0.00 |
| Venus Concept (VERO) | Canada | $0.003B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.003B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.002B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.002B | 0.00 |
| Avinger (AVGR) | United States | $0.002B | 0.00 |
| Nuwellis (NUWE) | United States | $0.001B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.000B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |